These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 26593898)

  • 1. Prostate Cancer Stem Cells: Research Advances.
    Jaworska D; Król W; Szliszka E
    Int J Mol Sci; 2015 Nov; 16(11):27433-49. PubMed ID: 26593898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into prostate cancer stem cells.
    Chen X; Rycaj K; Liu X; Tang DG
    Cell Cycle; 2013 Feb; 12(4):579-86. PubMed ID: 23370446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Stem Cell Biomarkers and Their Functional Mechanisms in Prostate Cancer.
    Zhang K; Zhou S; Wang L; Wang J; Zou Q; Zhao W; Fu Q; Fang X
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27447616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
    Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G
    Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
    Sánchez CA; Andahur EI; Valenzuela R; Castellón EA; Fullá JA; Ramos CG; Triviño JC
    Oncotarget; 2016 Jan; 7(4):3993-4008. PubMed ID: 26675257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression.
    Rybak AP; Bristow RG; Kapoor A
    Oncotarget; 2015 Feb; 6(4):1900-19. PubMed ID: 25595909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cells in prostate cancer initiation and progression.
    Lawson DA; Witte ON
    J Clin Invest; 2007 Aug; 117(8):2044-50. PubMed ID: 17671638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-coding RNAs in Prostate Cancer: From Discovery to Clinical Applications.
    Ceder Y
    Adv Exp Med Biol; 2016; 886():155-170. PubMed ID: 26659491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate stem cells and prostate cancer.
    Lawson DA; Xin L; Lukacs R; Xu Q; Cheng D; Witte ON
    Cold Spring Harb Symp Quant Biol; 2005; 70():187-96. PubMed ID: 16869753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MARKERS OF THE PROSTATE BASAL LAYER CELLS ARE EFFECTIVE INDICATORS OF ITS MALIGNANT TRANSFORMATION.
    Petrov NS; Voskresensky MA; Grosov RV; Korshak OV; Zaritsky AY; Vereschagina NA; Komyakov BK; Popov BV
    Tsitologiia; 2016; 58(7):526-33. PubMed ID: 30198661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel human prostate epithelial cell culture models for the study of carcinogenesis and of normal stem cells and cancer stem cells.
    Rhim JS; Li H; Furusato B
    Adv Exp Med Biol; 2011; 720():71-80. PubMed ID: 21901619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression analysis of putative stem cell markers in human benign and malignant prostate.
    Ugolkov AV; Eisengart LJ; Luan C; Yang XJ
    Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells.
    Rybak AP; Tang D
    Cell Signal; 2013 Dec; 25(12):2734-42. PubMed ID: 24036214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cells.
    Jiao J; Hindoyan A; Wang S; Tran LM; Goldstein AS; Lawson D; Chen D; Li Y; Guo C; Zhang B; Fazli L; Gleave M; Witte ON; Garraway IP; Wu H
    PLoS One; 2012; 7(8):e42564. PubMed ID: 22880034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen action during prostate carcinogenesis.
    Wang D; Tindall DJ
    Methods Mol Biol; 2011; 776():25-44. PubMed ID: 21796518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer stem cells: from theory to practice.
    Adamowicz J; Pakravan K; Bakhshinejad B; Drewa T; Babashah S
    Scand J Urol; 2017 Apr; 51(2):95-106. PubMed ID: 28635565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer.
    Yun EJ; Zhou J; Lin CJ; Hernandez E; Fazli L; Gleave M; Hsieh JT
    Clin Cancer Res; 2016 Feb; 22(3):670-9. PubMed ID: 26490309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigations of prostate epithelial stem cells and prostate cancer stem cells.
    Miki J
    Int J Urol; 2010 Feb; 17(2):139-47. PubMed ID: 20082648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prostate cancer stem cells: advances in current research].
    Wu G; Wu DL
    Zhonghua Nan Ke Xue; 2015 Feb; 21(2):170-4. PubMed ID: 25796694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification, characterization, and biological relevance of prostate cancer stem cells from clinical specimens.
    Kasper S
    Urol Oncol; 2009; 27(3):301-3. PubMed ID: 19414117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.